The number of tumor spheres after M-Gef-CD133 treatment is smaller compared with gefitinib (P < 0.001) and M-Gef (P < 0.001), although the number of tumor spheres was significantly increased after the treatment with gefitinib and M-Gef (P < 0.05). This evidence concerns the gene PROM1 and neoplasm.